Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
MarketWatch
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
Read the full story
This is a short summary. The complete article is published by MarketWatch.
Headline and summary aggregated from public news feeds. For information only — not financial advice.